222 related articles for article (PubMed ID: 33835738)
1. Clinical, Imaging, and Laboratory Markers of Premanifest Spinocerebellar Ataxia 1, 2, 3, and 6: A Systematic Review.
Kim DH; Kim R; Lee JY; Lee KM
J Clin Neurol; 2021 Apr; 17(2):187-199. PubMed ID: 33835738
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
3. Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
Tezenas du Montcel S; Petit E; Olubajo T; Faber J; Lallemant-Dudek P; Bushara K; Perlman S; Subramony SH; Morgan D; Jackman B; Figueroa KP; Pulst SM; Fauret-Amsellem AL; Dufke C; Paulson HL; Öz G; Klockgether T; Durr A; Ashizawa T;
Neurology; 2023 Apr; 100(17):e1836-e1848. PubMed ID: 36797067
[TBL] [Abstract][Full Text] [Related]
4. Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3.
Chandrasekaran J; Petit E; Park YW; du Montcel ST; Joers JM; Deelchand DK; Považan M; Banan G; Valabregue R; Ehses P; Faber J; Coupé P; Onyike CU; Barker PB; Schmahmann JD; Ratai EM; Subramony SH; Mareci TH; Bushara KO; Paulson H; Durr A; Klockgether T; Ashizawa T; Lenglet C; Öz G;
Ann Neurol; 2023 Apr; 93(4):686-701. PubMed ID: 36511514
[TBL] [Abstract][Full Text] [Related]
5. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
Joers JM; Deelchand DK; Lyu T; Emir UE; Hutter D; Gomez CM; Bushara KO; Eberly LE; Öz G
Ann Neurol; 2018 Apr; 83(4):816-829. PubMed ID: 29575033
[TBL] [Abstract][Full Text] [Related]
7. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
8. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.
Wilke C; Mengel D; Schöls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Schüle R; Reetz K; Jacobi H; Synofzik M
Neurology; 2022 May; 98(20):e1985-e1996. PubMed ID: 35264424
[TBL] [Abstract][Full Text] [Related]
9. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
Velázquez-Pérez L; Rodríguez-Labrada R; Canales-Ochoa N; Montero JM; Sánchez-Cruz G; Aguilera-Rodríguez R; Almaguer-Mederos LE; Laffita-Mesa JM
Lancet Neurol; 2014 May; 13(5):482-9. PubMed ID: 24657153
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6.
Linnemann C; Tezenas du Montcel S; Rakowicz M; Schmitz-Hübsch T; Szymanski S; Berciano J; van de Warrenburg BP; Pedersen K; Depondt C; Rola R; Klockgether T; García A; Mutlu G; Schöls L
Cerebellum; 2016 Apr; 15(2):165-73. PubMed ID: 26054379
[TBL] [Abstract][Full Text] [Related]
11. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
Wilke C; Haas E; Reetz K; Faber J; Garcia-Moreno H; Santana MM; van de Warrenburg B; Hengel H; Lima M; Filla A; Durr A; Melegh B; Masciullo M; Infante J; Giunti P; Neumann M; de Vries J; Pereira de Almeida L; Rakowicz M; Jacobi H; Schüle R; Kaeser SA; Kuhle J; Klockgether T; Schöls L; ; Barro C; Hübener-Schmid J; Synofzik M
EMBO Mol Med; 2020 Jul; 12(7):e11803. PubMed ID: 32510847
[TBL] [Abstract][Full Text] [Related]
12. Progression of Clinical and Eye Movement Markers in Preataxic Carriers of Machado-Joseph Disease.
de Oliveira CM; Leotti VB; Cappelli AH; Rocha AG; Ecco G; Bolzan G; Kersting N; Saraiva-Pereira ML; Jardim LB
Mov Disord; 2023 Jan; 38(1):26-34. PubMed ID: 36129443
[TBL] [Abstract][Full Text] [Related]
13. Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography.
Chen Z; Liao G; Wan N; He Z; Chen D; Tang Z; Long Z; Zou G; Peng L; Wan L; Wang C; Peng H; Shi Y; Tang Y; Li J; Li Y; Long T; Hou X; He L; Qiu R; Chen D; Wang J; Guo J; Shen L; Huang Y; Ashizawa T; Klockgether T; Tang B; Zhou M; Hu S; Jiang H
Mov Disord; 2023 Jun; 38(6):978-989. PubMed ID: 37023261
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3.
Abele M; Bürk K; Andres F; Topka H; Laccone F; Bösch S; Brice A; Cancel G; Dichgans J; Klockgether T
Brain; 1997 Dec; 120 ( Pt 12)():2141-8. PubMed ID: 9448569
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3.
Klockgether T; Skalej M; Wedekind D; Luft AR; Welte D; Schulz JB; Abele M; Bürk K; Laccone F; Brice A; Dichgans J
Brain; 1998 Sep; 121 ( Pt 9)():1687-93. PubMed ID: 9762957
[TBL] [Abstract][Full Text] [Related]
16. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?
Schöls L; Amoiridis G; Büttner T; Przuntek H; Epplen JT; Riess O
Ann Neurol; 1997 Dec; 42(6):924-32. PubMed ID: 9403486
[TBL] [Abstract][Full Text] [Related]
17. Frequency of the different mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD/SCA3 and DRPLA) in a large group of Brazilian patients.
Lopes-Cendes I; Teive HG; Calcagnotto ME; Da Costa JC; Cardoso F; Viana E; Maciel JA; Radvany J; Arruda WO; Trevisol-Bittencourt PC; Rosa Neto P; Silveira I; Steiner CE; Pinto Júnior W; Santos AS; Correa Neto Y; Werneck LC; Araújo AQ; Carakushansky G; Mello LR; Jardim LB; Rouleau GA
Arq Neuropsiquiatr; 1997 Sep; 55(3B):519-29. PubMed ID: 9629399
[TBL] [Abstract][Full Text] [Related]
18. [SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families].
Tang B; Wang D; Xia J
Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):819-22. PubMed ID: 9772474
[TBL] [Abstract][Full Text] [Related]
19. Challenges in sleep stage R scoring in patients with autosomal dominant spinocerebellar ataxias (SCA1, SCA2 and SCA3) and oculomotor abnormalities: a whole night polysomnographic evaluation.
Seshagiri DV; Sasidharan A; Kumar G; Pal PK; Jain S; Kutty BM; Yadav R
Sleep Med; 2018 Feb; 42():97-102. PubMed ID: 29458753
[TBL] [Abstract][Full Text] [Related]
20. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
